Molecular Medicine is the international, peer-reviewed, biomedical journal published by the Feinstein Institute for Medical Research (New York). Molecular Medicine strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention. Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of Molecular Medicine. The 2010 Journal Citation Report (JCR), showing impact factors calculated from citations of articles published in 2009 and 2008, lists Molecular Medicine with an impact factor of 5.908, putting it in the top 5% of publications.  JCR category rankings are as follows: Medicine, Research & experimental 11/106, Cell Biology 40/178, Biochemistry & Molecular Biology 44/286.  Molecular Medicine publishes work in the format of original research articles, review articles, editorials, commentaries and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.

Molecular Medicine places high priority on rapid publication. All content is published free online, ahead of print, within an average of 8 days after acceptance on our Web site www.molmed.org.  Following acceptance, papers are posted rapidly to PubMed, with an e-publication ahead of print citation. Molecular Medicine is an open access journal and does not embargo content.

 
Molecular Medicine gives science back to the scientists by offering:

• Free full-text access, without passwords or login requirements, to all publications dating back to the inaugural issue in November 1994.
  
  
• Automatic submission of your work to PubMed Central according to the NIH Public Access Policy.
  
  
• Rapid peer review. Average time to first decision is approximately four weeks.
  
  
• Pre-submission enquiry service. Check to see if your manuscript topic is suitable for Molecular Medicine - prior to formal submission.
  
  
• Free podcast. The Mollie Medcast is available for free on our Web site and in the iTunes Music Store (type “Mollie Medcast” in the search bar). Download summaries of papers and listen to them wherever your mp3 player takes you!

HIGHLIGHTS of the recent literature include:
     EPO Treatment Reduces Circulating Damage Markers
     Intraclonal Complexity in Chronic Lymphocytic Leukemia
     Liraglutide Prevents Hypoadiponectinemia-Induced IR
     Regional Brain Activation Patterns in SLE
     Transcription Factor Targeting in Breast Cancer
 
Like the field, the journal Molecular Medicine continues to grow as it scales the heights of modern biomedical science. It has captured the imagination of many of the best basic science and clinical investigators. Pick up an issue today and see for yourself!